Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study
scientific article
Author/s
author: Stefan Zeuzem, Julian Schulze zur Wiesch, Kristina Weber, Christoph Spinner, Guido Gerken, Michael Manns, Heiner Wedemeyer, Dorothee von Witzendorff, Markus Cornberg, Ulrich Spengler, Heiko von der Leyen
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.